Evitalife Science Private Limited
Pharmaceutical company manufacturing and trading drugs and medicines, incorporated in 2021 in Himachal Pradesh.
2021 | Solan, Himachal Pradesh (India) | Active
Evitalife Science Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 4 Year, 15 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.30 Cr
About Evitalife Science
Evitalife Science Private Limited (ESPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 February 2021 (Four years 15 days old ). Its registered office is in Solan, Himachal Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹3.30 Cr.
Rohit Barnwal and Subhash Kumar serve as directors at the Company.
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230HP2021PTC008354
- Company No.
008354
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Feb 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Pharma
Who are the key members and board of directors at Evitalife Science?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subhash Kumar  | Director | 11-Feb-2021 | Current |
| Rohit Barnwal | Director | 11-Feb-2021 | Current |
Financial Performance of Evitalife Science.
Enhance accessibility to Evitalife Science's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Evitalife Science?
Unlock access to Evitalife Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Evitalife Pharma Private Limited
Rohit Barnwal and Subhash Kumar are mutual person
Charges (Loans)
Open Charges
₹33.00 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 3.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Apr 2024 | Canara Bank | ₹3.30 Cr | Open |
How Many Employees Work at Evitalife Science?
Unlock and access historical data on people associated with Evitalife Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Evitalife Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Evitalife Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.